Daniel Nadler

Daniel Nadler is the Founder and CEO of OpenEvidence, an artificial intelligence medical knowledge platform based in Boston, Massachusetts. He previously served as the Co-founder and CEO of Kensho Technologies, a pioneering financial AI company that scaled to over 200 employees before being acquired by S&P Global for $550 million in 2018. Under his leadership, OpenEvidence recently secured $75 million in Series B funding at an estimated $500 million valuation and currently processes over one million monthly queries from tens of thousands of physicians. Nadler holds a PhD in computer science from Harvard University and formerly worked as the Director of Research for Financial Technology at Stanford University's School of Engineering. His career focuses on developing generative AI platforms that synthesize massive datasets for highly regulated, knowledge-intensive industries like healthcare and finance.